Euretina Logo, Links to homepage.
Euretina Logo, Links to homepage.

Episode 76: AI in Diabetic Retinopathy: Screening, Biomarkers and What Comes Next

Artificial intelligence is rapidly reshaping how we screen, classify, and treat diabetic retinal disease. Professor Aude Couturier (FRANCE), Professor Edoardo Midena (ITALY), and Professor Reinier Schlingemann (THE NETHERLANDS) discuss real-world AI applications in diabetic retinopathy — from population screening and imaging biomarkers to phenotyping and precision treatment in diabetic macular oedema.

Members can continue the conversation in the EURETINA Forum.

Browse all podcast episodes here.

Listen on your preferred podcast player:

Listen on your preferred podcast player:

IMPORTANT INFORMATION

Beware of fraudulent websites, emails and hotel booking offers

www.euretina.org is the only official website of the European Society of Retina Specialists.
 
Please be wary of websites, emails from third-party agencies using similar names, addresses or branding and purporting to represent Euretina.
 
This includes websites or companies offering Congress registration, hotel accommodation or travel services while claiming to be affiliated with Euretina.

Should you use any website other than www.euretina.org, or book accommodation through an unauthorised third-party site, you may be charged significantly more than the official registration fee, your hotel booking may not be valid, and you may not be registered for the event at all.
 
If you have any questions in relation to registration or accommodation for the Congress, these should only be directed to [email protected].